3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tooth, Impacted
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatoblastoma
1
Hematologic Neoplasms
1
Hemangioma, Cavernous, Central Nervous System
1
Hemangioma, Cavernous
1
Ganglioneuroblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Carcinoma, Renal Cell
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Watchful Waiting
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Hemangioma, Cavernous, Central Nervous System
×
Watchful Waiting
×
Clear all
NCT04467489
2025-08-11
Biomarkers of CASH
University of Chicago
Active not recruiting
1,040 enrolled